RJFSA
KLRS

Raymond James Financial Services Advisors’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Raymond James Financial Services Advisors’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		$48.9K Hold
2,630
– – ﹤0.01% 3339
2024
Q2 		$43.8K Hold
2,630
– – ﹤0.01% 3295
2024
Q1 		$45.7K Buy
2,630
+1,176
+81% +$20.4K ﹤0.01% 3294
2023
Q4 		$22.7K Buy
+1,454
New +$22.7K ﹤0.01% 3220